Upload
PPT-Figure Figure. Number of patients with severe acute respiratory syndrome (SARS)

PPT-Figure Figure. Number of patients with severe acute respiratory syndrome (SARS)

Author : roxanne | Published Date : 2023-08-30

Chan PK Ip M Ng K Chan RC Wu A Lee N et al Severe Acute Respiratory Syndromeassociated Coronavirus Infection Emerg Infect Dis 200391114531454 httpsdoiorg103201eid0911030421

severe outbreak outbreak severe acute respiratory sars admitted workers chan healthcare

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Figure Figure. Number of patien..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Figure Figure. Number of patients with severe acute respiratory syndrome (SARS): Transcript

Chan PK Ip M Ng K Chan RC Wu A Lee N et al Severe Acute Respiratory Syndromeassociated Coronavirus Infection Emerg Infect Dis 200391114531454 httpsdoiorg103201eid0911030421. suspect/confirmed novel coronavirus (nCoV) cases Coronaviruses are respiratory viruses and broadly distributed in humans and other mammals. Some causing illness in people and others that circulate am Loutfy MR, Wallington T, Rutledge T, Mederski B, Rose K, Kwolek S, et al. Hospital Preparedness and SARS. Emerg Infect Dis. 2004;10(5):771-776. https://doi.org/10.3201/eid1005.030717. Assiri AM, Abedi GR, Saeed AA, Abdalla MA, al-Masry M, Choudhry A, et al. Multifacility Outbreak of Middle East Respiratory Syndrome in Taif, Saudi Arabia. Emerg Infect Dis. 2016;22(1):32-40. https://doi.org/10.3201/eid2201.151370. Goldsmith CS, Tatti KM, Ksiazek TG, Rollin PE, Comer JA, Lee WW, et al. Ultrastructural Characterization of SARS Coronavirus. Emerg Infect Dis. 2004;10(2):320-326. https://doi.org/10.3201/eid1002.030913. Meltzer MI. Multiple Contact Dates and SARS Incubation Periods. Emerg Infect Dis. 2004;10(2):207-209. https://doi.org/10.3201/eid1002.030426. Harcourt J, Tamin A, Lu X, Kamili S, Sakthivel SK, Murray J, et al. Severe Acute Respiratory Syndrome Coronavirus 2 from Patient with Coronavirus Disease, United States. Emerg Infect Dis. 2020;26(6):1266-1273. https://doi.org/10.3201/eid2606.200516. Guo Z, Wang Z, Zhang S, Li X, Li L, Li C, et al. Aerosol and Surface Distribution of Severe Acute Respiratory Syndrome Coronavirus 2 in Hospital Wards, Wuhan, China, 2020. Emerg Infect Dis. 2020;26(7):1583-1591. https://doi.org/10.3201/eid2607.200885. Kaydos-Daniels SC, Olowokure B, Chang H, Barwick RS, Deng J, Lee M, et al. Body Temperature Monitoring and SARS Fever Hotline, Taiwan. Emerg Infect Dis. 2004;10(2):373-376. https://doi.org/10.3201/eid1002.030748. Chiu RW, Chim SS, Tong Y, Fung KS, Chan P, Zhao G, et al. Tracing SARS-Coronavirus Variant with Large Genomic Deletion. Emerg Infect Dis. 2005;11(1):168-170. https://doi.org/10.3201/eid1101.040544. Freuling CM, Breithaupt A, Müller T, Sehl J, Balkema-Buschmann A, Rissmann M, et al. Susceptibility of Raccoon Dogs for Experimental SARS-CoV-2 Infection. Emerg Infect Dis. 2020;26(12):2982-2985. https://doi.org/10.3201/eid2612.203733. Goldsmith CS, Ksiazek TG, Rollin PE, Comer JA, Nicholson WL, Peret T, et al. Cell Culture and Electron Microscopy for Identifying Viruses in Diseases of Unknown Cause. Emerg Infect Dis. 2013;19(6):886-891. https://doi.org/10.3201/eid1906.130173. Kratzel A, Todt D, V’kovski P, Steiner S, Gultom M, Thao T, et al. Inactivation of Severe Acute Respiratory Syndrome Coronavirus 2 by WHO-Recommended Hand Rub Formulations and Alcohols. Emerg Infect Dis. 2020;26(7):1592-1595. https://doi.org/10.3201/eid2607.200915. Hsueh P, Chen P, Hsiao C, Yeh S, Cheng W, Wang J, et al. Patient Data, Early SARS Epidemic, Taiwan. Emerg Infect Dis. 2004;10(3):489-493. https://doi.org/10.3201/eid1003.030571. Martines RB, Ritter JM, Matkovic E, Gary J, Bollweg BC, Bullock H, et al. Pathology and Pathogenesis of SARS-CoV-2 Associated with Fatal Coronavirus Disease, United States. Emerg Infect Dis. 2020;26(9):2005-2015. https://doi.org/10.3201/eid2609.202095.

Download Document

Here is the link to download the presentation.
"Figure Figure. Number of patients with severe acute respiratory syndrome (SARS)"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.

Related Documents

Figure 2 Figure 2. Standardized follow-up checklist of patients with severe acute

Figure 2 Figure 2. Standardized follow-up checklist of patients with severe acute
Figure 1 Figure 1. Middle East respiratory syndrome coronavirus (MERS-CoV) case-patients

Figure 1 Figure 1. Middle East respiratory syndrome coronavirus (MERS-CoV) case-patients
Figure 1 Figure 1. Assembly of severe acute respiratory syndrome–associated

Figure 1 Figure 1. Assembly of severe acute respiratory syndrome–associated
Figure 2 Figure 2. . . Cumulative frequency incubation period of severe acute respiratory

Figure 2 Figure 2. . . Cumulative frequency incubation period of severe acute respiratory
Figure 1 Figure 1. Cytopathic effect caused by severe acute respiratory syndrome coronavirus

Figure 1 Figure 1. Cytopathic effect caused by severe acute respiratory syndrome coronavirus
Figure 2 Figure 2. Spatial distribution of severe acute respiratory syndrome coronavirus

Figure 2 Figure 2. Spatial distribution of severe acute respiratory syndrome coronavirus
Figure 2 Figure 2. Advice given to callers to severe acute respiratory syndrome

Figure 2 Figure 2. Advice given to callers to severe acute respiratory syndrome
Figure Figure. Schematic illustration of the epidemiologic relationships between

Figure Figure. Schematic illustration of the epidemiologic relationships between
Figure 2 Figure 2. Detection of severe acute respiratory syndrome coronavirus 2 in swab

Figure 2 Figure 2. Detection of severe acute respiratory syndrome coronavirus 2 in swab
Figure 1 Figure 1. . . A) Cell culture isolate of severe acute respiratory syndrome coronavirus,

Figure 1 Figure 1. . . A) Cell culture isolate of severe acute respiratory syndrome coronavirus,
Figure 2 Figure 2. Effect of commercially available alcohols in inactivating SARS-CoV-2.

Figure 2 Figure 2. Effect of commercially available alcohols in inactivating SARS-CoV-2.
Figure 2 Figure 2. Timeline of therapeutic modalities used in 10 patients with

Figure 2 Figure 2. Timeline of therapeutic modalities used in 10 patients with
Figure 3 Figure 3. Immunostaining of severe acute respiratory syndrome coronavirus 2 in

Figure 3 Figure 3. Immunostaining of severe acute respiratory syndrome coronavirus 2 in